“…Although the synthetic agonist 4␣-PDD activates TRPV4 by directly binding to its TM3 and TM4 segments in a ligand-like manner (38), earlier studies indicate that AA-induced TRPV4 activation involves metabolism of AA by cytochrome P450 into 5,6-epoxyeicosatrienoic acid (5,6-EET) (34,35,39). A recent study has further proposed a potential 5,6-EET-binding site in TRPV4, which is formed by residues from the TM2-TM3 linker, TM4, and TM4-TM5 linker (65). However, other studies indicate that TRPV4 can also be activated by other EET regioisomers such as 11,12-EET (66, 67), AA (36,68), and endocannabinoids such as 2-arachidonoylglycerol (37).…”